Search
UTSW physician volunteering at Tokyo Olympics: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/olympics.html
Dr. Stephanie Tow, M.D., completed her first week of providing volunteer care at the Tokyo 2020 Olympics.
UT Southwestern to open DFW’s first state behavioral health hospital this summer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/dec-texas-behavioral-health-center.html
UT Southwestern Medical Center has been selected to operate the new Texas Behavioral Health Center – the first state acute care behavioral health hospital in the Dallas-Fort Worth area – announcing plans to care for its first patients this summer.
Media Relations: Newsroom - UT Southwestern
https://www.utsouthwestern.edu/newsroom/media-relations/
Information for media relations with UT Southwestern
UTSW builds AI-driven system to improve data collection : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/july-ai-model-speeds-medical-data-extraction.html
A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, featured in npj Digital Medicine, could
Study uncovers how biomolecular condensates cause some kidney cancers: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-biomolecular-kidney-cancers.html
A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical Center researchers suggests.
Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-kidney-cancer-drug.html
Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT Southwestern Medical Center, a new study shows. The findings, published in Cancer Discovery by a team at
UT Southwestern biochemist Zhijian ‘James’ Chen to receive 2026 Japan Prize: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-chen-japan-prize.html
Zhijian “James” Chen, Ph.D., Professor of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on how the body’s immune system protects us against threats such as bacteria and viruses, has been awarded the 2026 Japan Prize in Life Sciences – one of the highest
Researchers identify protein produced after stroke that triggers neurodegeneration: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/neurodegeneration.html
Researchers with the Peter O’Donnell Jr. Brain Institute at UT Southwestern have identified a new protein implicated in cell death that provides a potential therapeutic target that could prevent or delay the progress of neurodegenerative diseases following a stroke.
Same Difference: Two halves of the hippocampus have different gene activity: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/hippocampus.html
A study of gene activity in the brain’s hippocampus, led by UT Southwestern researchers, has identified marked differences between the region’s anterior and posterior portions.
Targeting Nsp1 protein could be a pathway for COVID-19 therapy : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/targeting-nsp1-protein.html
A study that identifies how a coronavirus protein called Nsp1 blocks the activity of genes that promote viral replication provides hope for new COVID-19 treatments.